Aclaris Therapeutics Statistics
NASDAQ: ACRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.68+0.28 (+8.24%)
Market open · Delayed 15 min · as of Oct 8, 2:16 PM ET
Aclaris Therapeutics by the numbers
Aclaris Therapeutics has a market capitalization of $541.7 million based on 147.20M shares outstanding. With trailing EPS of $-0.58, Aclaris Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 34.5% below its 50-day average and 17.5% below its 200-day average.
Average daily trading volume is 2.48M shares, or about $9.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACRS valuation vs. peer median
| Metric | ACRS | Peer median | Difference |
|---|---|---|---|
| Market cap | $541.69M | $505.85M | +7% |
| Avg. volume | 2.48M | 641.14K | +288% |
Peer median across 8 companies: DRUG, ALT, EOLS, MPLT, CTNM, PBYI, ARVN, CBIO.
Valuation
- Market cap
- $541.69M
- EPS (TTM)
- $-0.58
- Shares outstanding
- 147.20M
Price and trading
- Previous close
- 3.40
- Open
- 3.37
- Day range
- 3.18 – 3.81
- 52-week range
- 1.74 – 6.60
- 52-week change
- +84.78%
- Beta
- —
- Volume
- 4.44M
- Average volume
- 2.48M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 541.69M
- Forward Pe
- -4.67
- Eps
- -0.58
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.60
- Week52 Low
- 1.74
- Avg Volume
- 2.48M
- Shares Outstanding
- 147.20M
- Ma50
- 5.62
- Ma200
- 4.46
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -44.24%
- Pct From52w Low
- 111.49%